RBC analyst reduces profit estimates and price targets for domestic bank sector

RBC CM's Darko Mihelic cut bank price targets: BMO to $205 (from $219, -$14), BNS to $98 (from $106, -$8), CM to $147 (from $158, -$11), NA to $180 (from $193, -$13), TD to $138 (from $148, -$10); median forward target P/E lowered to 14.0x (from 15.0x) while covered banks trade at a median 12.9x on 2026 core EPS. Scotiabank trimmed Brookfield Asset Management TP/NAVPS by ~13% (‑$8) after an 18% YTD sell-off and lowered peer BN TP ~7%, citing limited credit/software exposure but valuation pressure from a FRE multiple cut to ~23x. TD Securities warns Canadian front-end yields look too high relative to domestic fundamentals and David Rosenberg added 2-year Canadian bonds to his model portfolio, signalling tactical value in short-dated sovereigns.

Analysis

Re-rating pressure in Canadian large-cap banks will amplify second-order effects beyond headline multiples: capital deployment (buybacks/dividends) is the first discretionary lever management will throttle, but the more persistent hit is to mortgage pricing power and deposit beta dynamics. A 25–50bp sustained increase in funding costs can shave low-single-digit EPS for retail-heavy franchises over 12–24 months by compressing NIM and slowing originations, and that impact is non-linear if credit growth stumbles.

Alternatives and fee-bearing asset managers are now effectively trading as duration assets tied to public credit sentiment and 10Y moves; firms with lower direct-lending share and higher REAL-asset/IG exposure have a shorter path back to normalized fee growth if long-term rates stabilize. The immediate NAV hit from FRE multiple compression is mechanically larger than temporary coupon volatility, so expect valuation-led dispersion across the group to persist into the next fundraising windows.

Front-end Canadian rates dislocation creates a tactical convexity opportunity: if the BoC is ultimately forced to ease on soft core inflation prints, front-end rally will be sharp and fast, compressing front-end term premia and benefitting balance-sheet duration for banks and insurers. Conversely, an unexpectedly sticky data sequence would reprice credit spreads and force mark-to-market pain for levered credit strategies, so position sizing and stop frameworks must reflect this asymmetry.

Key catalysts to watch in the next 3–9 months are quarterly fee/fundraising updates from asset managers, Canada core-inflation prints and BoC forward guidance, and early signs of credit deterioration in consumer delinquencies; any of these could reverse current trajectories quickly and are high-conviction triggers for re-rating trades.

Key Decisions for Investors

• Long BAM (6–12m): initiate a 6–8% portfolio position in BAM and affiliate BN on pullbacks. Risk/reward ~+30% upside if FRE/NAV rerating resumes and fundraising stabilizes; downside ~-20% if long-rates persistently reprice. Use 6–9m call spread to lever conviction while capping downside if preferred.
• Pair trade — long TD / short BNS (3–9m): overweight TD vs underweight BNS to express asymmetric exposure to higher‑quality margin and deposit mix. Target a 1.5–2.0 notch net exposure (e.g., 1.5% long TD, 1% short BNS). Reward from relative NIM/credit resilience; risk if wholesale funding or macro shock hits both equally.
• Rates play — long CAN 2Y futures or receivers (1–3m): buy 2Y Canada front-end duration into upcoming CPI prints and BoC communications. High conviction; reward is rapid P&L capture on a 25–75bp rally in 2Y yields, risk is further front-end sell-off if BoC signals higher for longer.
• Short BMO via options (6m): buy 6‑month puts ~10% OTM or establish a bear put spread to limit premium spend; position size small (1–2% notional). Objective is to capture downside from multiple compression and funding pressure; hedge by reducing size if consumer delinquency signals remain benign.
• Risk control: set hard stop/hedge triggers — unwind equity bank exposure if Canada 2Y yield moves up >40bp from entry or if national core CPI prints >0.45% m/m, and trim BAM/BN exposure by 25% on a 100bp sustained rise in 10Y that materially widens FRE multiples.